GCT Semiconductor files legal opinion for ATM shares
GCT Semiconductor Holding, Inc. filed a current report to add a legal opinion supporting the validity of shares issuable under its At Market Issuance Sales Agreement.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
GCT Semiconductor Holding, Inc. filed a current report to add a legal opinion supporting the validity of shares issuable under its At Market Issuance Sales Agreement. The opinion, from Morgan, Lewis & Bockius LLP, relates to a prospectus supplement filed on June 18, 2026, which supplements the Company’s shelf registration statement on Form S-3 (File No. 333-286316) that was declared effective on April 9, 2025. The filing clarifies that it is not itself an offer to sell or a solicitation to buy the common stock referenced.
8-K Event Classification
Item 9.01 — Financial Statements and Exhibits
1 item
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Prospectus supplement date: June 18, 2026
Form S-3 file number: 333-286316
Form S-3 effective date: April 9, 2025
+1 more
4 metrics
Prospectus supplement date
June 18, 2026
Date of prospectus supplement referenced for ATM shares
Form S-3 file number
333-286316
Shelf registration statement referenced in the filing
Form S-3 effective date
April 9, 2025
Date SEC declared the S-3 registration effective
Warrant exercise price
$11.50 per share
Exercise price for each whole warrant listed on NYSE
Key Terms
At Market Issuance Sales Agreement, prospectus supplement, registration statement on Form S-3, emerging growth company, +1 more
5 terms
At Market Issuance Sales Agreement financial
"shares of common stock of the Company issuable under the At Market Issuance Sales Agreement"
An at market issuance sales agreement is a setup where a company arranges for an agent to sell newly issued shares directly into the public market at the current trading price, usually over time as needed. It matters to investors because it gives the company quick, flexible access to cash without setting a fixed price, but can dilute existing shareholders and affect the stock’s supply and short‑term price behavior—like a shop owner adding extra items to a shelf and selling them at whatever the going price is.
prospectus supplement regulatory
"pursuant to a prospectus supplement filed on June 18, 2026"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
registration statement on Form S-3 regulatory
"which supplements the registration statement on Form S-3 (File No. 333-286316)"
A registration statement on Form S‑3 is a short, standardized filing a qualified public company uses to register new securities with regulators so they can be sold to investors; think of it as a pre-approved, reusable permission slip that speeds up future offerings. It matters to investors because it lets the company raise money more quickly and cheaply — which can fund growth or pay debt — but may also lead to share dilution or change in ownership, so it affects value and liquidity.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Opinion of Morgan, Lewis & Bockius LLP financial
"5.1 | | Opinion of Morgan, Lewis & Bockius LLP"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did GCT Semiconductor (GCTS) disclose in this 8-K filing?
GCT Semiconductor filed a report to include a legal opinion on the validity of shares issuable under its At Market Issuance Sales Agreement, tied to a June 18, 2026 prospectus supplement and an effective Form S-3 shelf registration.
What is the purpose of the legal opinion filed by GCT Semiconductor (GCTS)?
The legal opinion from Morgan, Lewis & Bockius LLP confirms the legality of GCT Semiconductor’s common stock issuable under its At Market Issuance Sales Agreement, which operates under a June 18, 2026 prospectus supplement to an effective Form S-3 registration statement.
How does the June 18, 2026 prospectus supplement relate to GCT Semiconductor’s Form S-3?
The June 18, 2026 prospectus supplement updates and supplements GCT Semiconductor’s Form S-3 registration statement (File No. 333-286316), which the SEC declared effective on April 9, 2025, specifically for shares issuable under the At Market Issuance Sales Agreement.
Does this GCT Semiconductor (GCTS) filing represent an offer or sale of securities?
The filing explicitly states it does not constitute an offer to sell or solicitation to buy the common stock referenced, nor any sale in jurisdictions where such activities would be unlawful before proper registration or qualification under applicable state securities laws.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates